We remain focused on ensuring our smooth and orderly withdrawal from the EU with adeal as soon as possible.
We have now reached agreement with the EU on an extension until October 31st at thelatest, with the option to leave earlier as soon as a deal has been ratified.
Although Parliament have rejected leaving without a deal multiple times, this remainsthe legal default at the end of the extension period.
As a responsible government we’ve been preparing to minimise any disruption in theevent of no deal for over two years.
In light of the extension that has now been agreed, departments will make sensibledecisions about the timing and pace at which some of this work is progressing, but wewill continue to prepare for all Brexit scenarios.
When necessary we will continue to update our advice on gov.uk/euexit on how peopleshould prepare.

1.VMD’s EU Exit Information Hub was first published on 21st February and continues to beupdated as information becomes available.
Special Imports: The process for importing medicines into the UK for animaltreatment is being improved. Once live, the decision as to whether you (as aveterinary surgeon) need one import certificate per named animal, or for allanimals of one species under your care, will be based on the VMD benefit/riskassessment of the proposed import product only.
Full details of the improvements can be found at http://www.vmd.defra.gov.uk/online/wheel/SpecialImports.pdf

2.Together with the pharmaceutical industry, VMD has well-established procedures to dealwith medicine shortages. This includes working closely with those operating in the supplychain to ensure that risks are minimised when they do arise. VMD published on 19thMarch an outline of its multi-layered approach to support the industry to reduce anysupply disruption in veterinary medicines. These plans include:
Strengthening the established processes and resources used to deal withshortages in the event that they do occur, including extending the VMD’s industrysupply reporting system in order to understand the reasons for potential supplyissues and take appropriate action.
Permitting the use of medicines authorised in other countries which can beimported through the VMD’s Special Import scheme.
Anyone who experiences supply problems should notify VMD at supply@vmd.defra.gsi.gov.uk

3.Importing and exporting equines

•The processes for importing and exporting equines between the UK and the EU will remain as they are now during the extension to Article 50. The UK will remain a part of the Tri-partite Agreement (TPA), which governs the movement of equines between the UK, Ireland and France during this period. Details of the current process for exporting equines to the EU are available on Gov.uk.

4.Following the Article 50 extension in April, the European Commission have confirmed a further SCoPAFF vote will be required to list the UK prior to a potential no deal EU Exit in the future. We are confident the UK will continue to meet the requirements for listing should that be required.

If you have any outstanding queries or additional questions that you feel are yet to be answered, please get in contact with us: StakeholdersTeam@defra.gov.uk